Mucolipidosis type IV
MONDO:0009653A lysosomal disease characterized by psychomotor delay, progressive visual impairment, and achlorhydria.
Also known as: ML 4, ML IV, ML4, MLIV, Mucolipidosis IV, mucolipidosis IV, mucolipidosis type 4, mucolipidosis type IV
41 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
VR headsets tested as a possible treatment for blindness
Disease control TerminatedThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Rare disease study aims to map MLIV's natural course
Knowledge-focused TerminatedThis study followed 7 people with Mucolipidosis Type IV (MLIV) to learn how the disease naturally progresses. Researchers used tests like neuropsychological exams, blood and urine tests, and brain MRIs to find better ways to measure the disease. The goal was to improve future cli…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC